// App-Quantinova.ai

: Incidence and Risk Factors for Second Malignancies after Transplant in Long Term Survivors of Allogeneic Haematopoietic Stem Cell Transplant: A Single Centre Experience

Researchers

Presenter

  • Mohammed Snober

Principal Investigators

  • Richard Syzdlo

  • Jane Apperley

  • Aristeidis Chaidos

  • Edward Kanfer

  • Dragana Milojkovic

  • Eduardo Olavarria

  • Renuka Palanicawandar

  • Jiri Pavlu

  • Jeannie F Todd

  • Nina Salooja

Medical Centers

  • Sir Alexander Fleming Building, South Kensington Campus, Imperial College, Imperial College, London, London, United Kingdom

  • Imperial College London, Centre For Haematology, London, United Kingdom

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

  • Centre for Haematology, Department of Medicine, Imperial College London, London, United Kingdom

  • Imperial College, Department of Haematology, Hammersmith Hospital, London, United Kingdom

  • Department of Haematology, Imperial College London, Hammersmith Hospital, London, United Kingdom

  • Centre for Haematology, Imperial Collegel, London, United Kingdom

  • Department of Haematology, Hammersmith Hospital, Imperial Healthcare NHS Trust, London, United Kingdom

  • Imperial College at Hammersmith Hospital, London, United Kingdom

  • Imperial College London, Centre For Haematology, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Skin carcinoma

  • Lymphomas

  • Melanoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved